| Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms A Michels, N Ho, CJ Buchholz Molecular Therapy 30 (7), 2401-2415, 2022 | 35 | 2022 |
| In vivo generation of CAR T cells in the presence of human myeloid cells N Ho, S Agarwal, M Milani, A Cantore, CJ Buchholz, FB Thalheimer Molecular Therapy-Methods & Clinical Development 26, 144-156, 2022 | 11 | 2022 |
| Dasatinib is a potent enhancer for CAR T cell generation by CD3-targeted lentiviral vectors AH Braun, AM Frank, N Ho, CJ Buchholz Molecular Therapy Methods & Clinical Development 28, 90-98, 2023 | 4 | 2023 |
| Precision medicine F Michael, EW Newell | 4 | |
| CAR Gene Delivery by T‐cell Targeted Lentiviral Vectors is Enhanced by Rapamycin Induced Reduction of Antiviral Mechanisms FT Charitidis, E Adabi, N Ho, AH Braun, C Tierney, L Strasser, ... Advanced Science 10 (35), 2302992, 2023 | 1 | 2023 |
| Early induction of cytokine release syndrome by rapidly generated CAR T cells in preclinical models A Jamali, N Ho, A Braun, E Adabi, FB Thalheimer, CJ Buchholz EMBO Molecular Medicine 16 (4), 784-804, 2024 | | 2024 |
| MULTI-OMICS INFORMED ENHANCEMENT OF CAR GENE DELIVERY BY RAPAMYCIN, INDUCED REDUCTION OF ANTIVIRAL MECHANISMS AGAINST T-CELL TARGETED LENTIVIRAL VECTORS F Charitidis, E Adabi, N Ho, A Braun, C Tierney, L Strasser, F Thalheimer, ... HUMAN GENE THERAPY 34 (21-22), A4-A5, 2023 | | 2023 |
| 1260 Rapid cytokine release syndrome caused by short-term CAR T cells in a preclinical mouse model A Jamali, N Ho, A Braun, E Adabi, FB Thalheimer, CJ Buchholz Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes L Kapitza, N Ho, T Kerzel, AM Frank, FB Thalheimer, A Jamali, T Schaser, ... Frontiers in Immunology 14, 1183698, 2023 | | 2023 |
| Human myeloid enhanced model systems: Tools for advanced evaluation of short-term CAR T cells and in vivo CAR T cell generation N Ho Technische Universität Darmstadt, 2023 | | 2023 |
| Early induction of cytokine release syndrome by rapidly generated CAR T cells in a preclinical mouse model N Ho, A Jamali, A Braun, E Adabi, FB Thalheimer, CJ Buchholz bioRxiv, 2022.11. 12.515207, 2022 | | 2022 |
| In vivo CAR T cell generation in humanized NSG-SGM3 mice N Ho, S Agarwal, CJ Buchholz, FB Thalheimer HUMAN GENE THERAPY 32 (19-20), A90-A90, 2021 | | 2021 |
